Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sally Ye
Observed name:
Ye, Sally
Institution:
Boehringer Ingelheim (United States)
Observed institution:
Boehringer Ingelheim (United States)
ORCID:
0009-0006-0597-6039
Observed ORCID:
0009-0006-0597-6039
OpenAlex ID:
A5005645230
Using Multiple Platforms for Critical Reagents Selection Process to Support Pharmacokinetic Ligand-Binding Assay Development
2021
·
Elisa Oquendo
, Xu Lin
, et al.
·
Bioanalysis
·
6
Overcoming target interference in bridging anti-drug antibody (ADA) assay by optimizing sample treatment
2025
·
Sally Ye
, Janice Gambardella
, et al.
·
Bioanalysis
·
3
A Data-driven Stepwise Approach to Cross Validation of Clinical Anti-Drug Antibody (ADA) Assays
2026
·
Sally Ye
, Yan Mao
, et al.
·
The AAPS Journal
PDF
PKPD investigation of BI-S across blood-ocular barrier
2026
·
Xianwei Zhang
, Sally Ye
, et al.
PDF
Tailoring the Methods of Conjugation and Characterization for a Replication-Competent, Live, Viral Vector
2025
·
Elise Ishida
, Richard Dambra
, et al.
·
Bioconjugate Chemistry
Show more works
View as search
Works count:
6
Citation count:
9
H-index:
2
I10-index:
Year
Topic
Type